Vascular Pharmaceuticals (United States)
- Research works
- 4 ▼ 69% vs 2013–17
- Citations
- 75 20.4 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Vascular Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Vascular Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Respiratory and Cough-Related Research, Ion Channels and Receptors and Asthma and respiratory diseases.
- 1 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
- 2 Ion Channels and Receptors Sensory Systems 0 works
- 3 Asthma and respiratory diseases Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Vascular Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 69% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chapel Hill
- University of North Carolina at Chapel Hill
- University of North Carolina Health Care
- University of North Carolina Hospitals
- Communities In Schools of Orange County
- Rho (United States)
- Chapel Hill Carrboro City Schools
- Renaissance Computing Institute
- Horizon Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.